The Beauty Health Company (NASDAQ:SKIN) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of The Beauty Health Company (NASDAQ:SKINGet Rating) have earned an average recommendation of “Moderate Buy” from the twelve analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $26.00.

A number of equities research analysts recently commented on SKIN shares. Benchmark lifted their target price on Beauty Health from $18.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, March 14th. JPMorgan Chase & Co. started coverage on Beauty Health in a report on Friday, March 11th. They set an “overweight” rating and a $24.00 target price for the company. Piper Sandler decreased their target price on Beauty Health from $26.00 to $24.00 in a report on Wednesday, May 11th. DA Davidson decreased their price target on Beauty Health from $35.00 to $24.00 in a report on Wednesday, May 11th. Finally, Canaccord Genuity Group decreased their price target on Beauty Health from $27.00 to $22.00 in a report on Wednesday, May 11th.

Several institutional investors have recently bought and sold shares of the company. BlackRock Inc. increased its position in shares of Beauty Health by 5.8% in the first quarter. BlackRock Inc. now owns 7,778,389 shares of the company’s stock valued at $131,300,000 after buying an additional 423,084 shares in the last quarter. William Blair Investment Management LLC increased its position in shares of Beauty Health by 232.2% during the fourth quarter. William Blair Investment Management LLC now owns 6,251,906 shares of the company’s stock worth $151,046,000 after purchasing an additional 4,370,217 shares in the last quarter. Invesco Ltd. increased its position in shares of Beauty Health by 8.8% during the first quarter. Invesco Ltd. now owns 5,020,317 shares of the company’s stock worth $84,742,000 after purchasing an additional 407,849 shares in the last quarter. Luxor Capital Group LP increased its position in shares of Beauty Health by 29.7% during the fourth quarter. Luxor Capital Group LP now owns 4,108,912 shares of the company’s stock worth $99,271,000 after purchasing an additional 941,138 shares in the last quarter. Finally, Wellington Management Group LLP increased its position in shares of Beauty Health by 5.5% during the first quarter. Wellington Management Group LLP now owns 2,394,159 shares of the company’s stock worth $40,414,000 after purchasing an additional 125,195 shares in the last quarter. Institutional investors and hedge funds own 72.01% of the company’s stock.

Shares of NASDAQ SKIN opened at $12.47 on Thursday. The company has a debt-to-equity ratio of 2.14, a quick ratio of 13.57 and a current ratio of 14.25. The company has a market cap of $1.87 billion, a PE ratio of -3.67 and a beta of 1.71. The business has a 50-day simple moving average of $12.90 and a two-hundred day simple moving average of $16.12. Beauty Health has a fifty-two week low of $9.94 and a fifty-two week high of $30.17.

Beauty Health (NASDAQ:SKINGet Rating) last released its earnings results on Tuesday, May 10th. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Beauty Health had a negative return on equity of 0.01% and a negative net margin of 117.84%. The firm had revenue of $75.40 million for the quarter, compared to analyst estimates of $68.15 million. The firm’s revenue for the quarter was up 58.7% compared to the same quarter last year. On average, sell-side analysts predict that Beauty Health will post 0.06 earnings per share for the current fiscal year.

Beauty Health Company Profile (Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.

Read More

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.